Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
It’s wild to think that a math puzzle from the 1200s is now helping power AI, encryption, and the digital world we live in.
ZDNET sat down with Andrew Ng at AI Dev 25 in New York to talk about developer futures, responsible AI, and why AGI is overhyped.